使,

Xiangyi Wang1,2, Jin Zhang1,2, Kailu Zheng3

  • 1State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.

概括

研究人员开发了一种新的策略,使用胆修饰的小分子药物联合体 (SMDC) 向癌细胞. 这种方法利用瘤的代谢脆弱性来增强化疗输送和降低毒性.